Original articles

Long-term efficacy of point application therapy on different acupoints and durations in the treatment of asthma: a randomized controlled trial

  • Yutong JIN ,
  • Lingtao WU ,
  • Yanglu GUO ,
  • Chong XIA ,
  • Binyan YU ,
  • Lihua XUAN
Expand
  • 1 Department of Acupuncture and Moxibustion, the First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou 310006, China
    2 Department of Massage, Hangzhou Fuyang Hospital of Traditional Chinese Medicine, Hangzhou 311400, China
    3 Department of Acupuncture and Moxibustion, Hangzhou Fuyang Hospital of TCM Orthopedics and Traumatology, Hangzhou 311400, China
Prof. XUAN Lihua, Department of Acupuncture and Moxibustion, the First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou 310006, China. xlh1083@163.com. Telephone:+86-13588420630

Received date: 2022-06-26

  Accepted date: 2022-10-18

  Online published: 2023-01-10

Supported by

Research and Application of Key Techniques of Point Application Therapy for Treating Winter Diseases and Summer Diseases to Prevent and Treat Respiratory Allergic Diseases(2014C03046-2);Study on the Mechanism of Point Application Therapy Regulating Autophagy of Airway Epithelial Cells in the Treatment of Asthma Based on AMPK/mTOR Signal Pathway(82004454);based on the Theory of "Lung Intestine Axis", a Comparative Study on the Therapeutic Effect of Different Point Application Therapy on Patients with AnaphyLactic Asthma in Remission Stage(2021ZQ035)

Abstract

OBJECTIVE: To optimise point application therapy for the treatment of asthma.
METHODS: A total of 456 patients with asthma were randomly divided into treatment groups 1, 2, and 3, with 152 patients each. The Dazhui (GV14), Feishu (BL13), Xinshu (BL15), Geshu (BL17), Pishu (BL20), Shenshu (BL23), and Guanyuan (CV4) acupoints were selected for treatment groups 1 and 2, with 2 and 4 h of application, respectively. The Feishu (BL13), Xinshu (BL15), and Geshu (BL17) acupoints were selected in group 3, with 2 h of application. All patients underwent application of the “prevention of disease” plaster during the dog days of summer (approximately July and August each year) between 2015 and 2019.
RESULTS: The analysis showed that the numbers of asthma attacks and total serum immunoglobulin E (IgE) levels of the three groups after treatment were significantly lower than those before treatment. In addition, the reductions in treatment groups 1 and 2 were more significant than those in group 3. The total treatment efficacy rates and post-treatment quality of life scores of the patients in treatment groups 1 and 2 were significantly higher than those in group 3.
CONCLUSIONS: Point application therapy can effectively improve the clinical symptoms of patients with asthma, reduce the number of attacks, improve the quality of life, and decrease the total serum IgE level. The choice of acupuncture points, but not the length of the application time, influenced the therapeutic effect of point application therapy in asthma.

Cite this article

Yutong JIN , Lingtao WU , Yanglu GUO , Chong XIA , Binyan YU , Lihua XUAN . Long-term efficacy of point application therapy on different acupoints and durations in the treatment of asthma: a randomized controlled trial[J]. Journal of Traditional Chinese Medicine, 2023 , 43(1) : 146 -153 . DOI: 10.19852/j.cnki.jtcm.2023.01.013

References

1 Global Initiative for Asthma. Difficult-to-treat and severe asthma in adolescent and adult patients: diagnosis and management. A GINA pocket guide for health professionals. Version 3 Fontana, WI: Global Initiative for Asthma; 2021. Available from URL: https://www.ginasthma.org/reports
2 To T, Stanojevic S, Moores G, et al. Global asthma prevalence in adults: findings from the cross-sectional world health survey. BMC Public Health 2012; 12: 204.
3 Nathan RA, Meltzer EO, Derebery J, et al. The prevalence of nasal symptoms attributed to allergies in the United States: findings from the burden of rhinitis in an America survey. Allergy Asthma Proc 2008; 29: 600-8.
4 Song SJ, Luo M. Advances in research on autophagy and respiratory diseases. World Latest Inf (Electron Version) 2019; 19: 38-9.
5 Sobieraj DM, Weeda ER, Nguyen E, et al. Association of inhaled corticosteroids and long-acting β-agonists as controller and quick relief therapy with exacerbations and symptom control in persistent asthma: a systematic review and Meta-analysis. JAMA 2018; 319: 1485-96.
6 Demenais F, Margaritte-Jeannin P, Barnes KC, et al. Multi-ancestry association study identifies new asthma risk loci that colocalize with immune-cell enhancer marks. Nat Genet 2018; 50: 42-53.
7 Allen CS, Yeung JH, Vandermeer B, Homik J. Bisphosphonates for steroid-induced osteoporosis. Cochrane Database Syst Rev 2016; 10: CD001347.
8 Spang C, Chen J, Backman LJ. The tenocyte phenotype of human primary tendon cells in vitro is reduced by glucocorticoids. BMC Musculoskelet Disord 2016; 17: 467.
9 Hu J, Zhang C, Zhao SM, et al. A systematic review and meta-analysis of acupoint application combined with Western Medicine therapy in the treatment of bronchial asthma. Ann Palliat Med 2021; 10: 11473-81.
10 Wei CL, Zhang X, Li PF, Li W. Acupoint herbal patching during Sanfu Days on reducing frequency of acute asthma attack in children: a systematic review and Meta-analysis. Medicine 2020; 99: e18962.
11 Shi K, Wu W, Liu L, et al. Optimization of acupoint application scheme in the treatment of bronchial asthma based on the orthogonal design method. Zhong Guo Zhen Jiu 2017; 37: 571-5.
12 Zhang KY, Xu SW, Yang Y, Shou Y, Jiang H, Zhang B. Clinical study of optimizing acupoint combining in treatment of bronchial asthma with acupoint application. J Acupunct Tuina Sci 2019; 17: 344-9.
13 Wu X, Peng J, Li G, Zhang W, Liu G, Liu B. Efficacy evaluation of summer acupoint application treatment on asthma patients: a two-year follow-up clinical study. J Tradit Chin Med 2015; 35: 21-7.
14 Wen BL, Zhou H, Liu BY, et al. Analysis on acupoint prescription for acupoint sticking therapy of treating winter diseases in summer for preventing and curing chronic cough and asthma. Zhong Guo Zhen Jiu 2010; 30: 647-52.
15 Asthma Group, Respiratory Branch of Chinese Medical Association. Guidelines for prevention and treatment of bronchial asthma (2016). Chin J Tuberc Respir Dis 2016; 39: 675-97.
16 Chinese Acupuncture and Moxibustion Association. Evidence-based clinical practice guidelines of acupuncture and moxibustion: bronchial asthma in adults. Beijing: China Press of Traditional Chinese Medicine, 2015: 14-5.
17 Li M, Yin K, Cai Y. Asthmology. 2nd ed. Beijing: People’s Medical Publishing House, 2005: 734-6.
18 Zhang B. Internal medicine of Traditional Chinese Medicine. Shang-hai: Shanghai Scientific and Technical Publishers, 1985; 59-60.
19 Vieira Braga FA, Kar G, Berg M, et al. A cellular census of human lungs identifies novel cell states in health and in asthma. Nat Med 2019; 25: 1153-63.
20 Saunders R, Kaul H, Berair R, et al. DP2 antagonism reduces airway smooth muscle mass in asthma by decreasing eosinophilia and myofibroblast recruitment. Sci Transl Med 2019; 11: 479.
21 Chen S, Jin YT, Zhu ZY, et al. In vivo study on site of action of sinapine thiocyanate following acupoint herbal patching. Evid Based Complement Alternat Med 2018; 2018: 1-6.
22 Xuan L, inven tor. A kind of plaster for preventing disease and its preparation. China ZL201010154886. 2012 Jun 13.
Outlines

/